封面
市場調查報告書
商品編碼
1747309

非處方抗真菌藥物市場:按產品類型、活性成分、應用、使用者、分銷管道和地區分類

OTC Topical Antifungals Market, By Product Type, By Active Ingredient, By Application, By User, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 166 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

2025 年全球非處方抗真菌藥物市場規模估計為 32.8 億美元,預計到 2032 年將達到 49 億美元,2025 年至 2032 年的年複合成長率(CAGR)為 5.9%。

報告範圍 報告詳細資訊
基準年 2024 2025年的市場規模 32.8億美元
效能數據 從2020年到2024年 預測期 2025年至2032年
預測期:2025-2032年複合年成長率: 5.90% 2032年價值預測 49億美元

近年來,由於真菌感染疾病的日益流行和非處方藥需求的不斷成長,全球 OTC 外用抗真菌藥物市場出現了顯著成長。外用抗真菌藥物物是直接塗抹在皮膚、指甲和頭髮上,用於治療各種真菌感染疾病(如足癬、癬和念珠菌症)的藥物。市場提供各種各樣的產品,如乳膏、軟膏、噴霧劑和粉劑,這些產品無需處方箋即可輕鬆取得。這些產品的便利性和可用性使其在尋求快速有效緩解真菌感染疾病的消費者中廣受歡迎。隨著個人衛生和自我護理意識的不斷增強,全球 OTC 外用抗真菌藥物市場預計將進一步擴大,為製造商和零售商提供有利可圖的機會。

市場動態

全球非處方抗真菌藥物市場受到多種關鍵因素的影響,這些因素推動了其成長,帶來了挑戰,也提供了機會。主要促進因素之一是全球真菌感染疾病的增加,尤其是在熱帶氣候和衛生條件差的新興國家。此外,糖尿病盛行率的上升使人們更容易受到真菌感染疾病,這也促進了市場的成長。此外,人們對個人衛生和及時治療真菌感染疾病重要性的認知不斷提高,也導致對非處方外用抗真菌藥物的需求增加。然而,市場上也存在一些限制因素,例如處方藥和家庭療法等替代治療方案的可用性,這可能會限制市場的成長潛力。此外,一些外用抗真菌藥物會引起皮膚刺激和過敏反應等副作用,這可能會導致一些消費者不願意使用這些產品。儘管存在這些挑戰,但對於那些開發創新和有針對性的配方以滿足特定消費者需求和偏好的製造商來說,市場代表著一個巨大的商機。對天然和有機抗真菌產品的需求不斷成長以及向新興市場擴張的潛力為全球非處方抗真菌藥物市場提供了有希望的成長途徑。

本研究的主要特點

  • 本報告對全球非處方抗真菌藥物市場進行了詳細分析,並以 2024 年為基準年,給出了預測期(2025-2032 年)的市場規模(十億美元)和年複合成長率(CAGR%)。
  • 它還強調了各個領域的潛在商機,並解釋了該市場有吸引力的投資提案矩陣。
  • 它還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域前景和主要企業採用的競爭策略的主要考察。
  • 它根據公司亮點、產品系列、關鍵亮點、財務業績和策略等參數,對全球非處方抗真菌藥物市場的主要企業進行了概述。
  • 本報告的見解將使負責人和企業經營團隊能夠就未來的產品發布、新興車型、市場擴張和行銷策略做出明智的決策。
  • 全球非處方外用抗真菌劑市場報告針對該行業的各個相關人員,包括投資者、供應商、產品製造商、經銷商、新進入者和金融分析師。
  • 相關人員可以透過分析全球非處方抗真菌藥物市場所使用的各種策略矩陣來簡化決策。

目錄

第1章 調查目的與前提條件

  • 研究目標
  • 先決條件
  • 簡稱

第2章 市場展望

  • 報告描述
    • 市場定義和範圍
  • 執行摘要

第3章市場動態、法規與趨勢分析

  • 市場動態
  • 驅動程式
  • 限制因素
  • 機會
  • 影響分析
  • 主要進展
  • 監管情景
  • 產品發布/核准
  • PEST分析
  • 波特分析
  • 併購場景
  • 產業趨勢

4. 2020 年至 2032 年全球 OTC 外用抗真菌藥物市場(依產品類型)

  • 奶油
  • 軟膏
  • 粉末
  • 凝膠
  • 洗劑

5. 2020 年至 2032 年全球 OTC 外用抗真菌藥物市場(按活性成分分類)

  • Clotrimazole
  • Miconazole
  • Terbinafine
  • Ketoconazole
  • 托萘酯
  • 其他

6. 2020 年至 2032 年全球 OTC 外用抗真菌藥物市場(依應用)

  • 皮癬菌病菌感染
  • 酵母菌感染疾病
  • 指甲感染疾病
  • 足癬

7. 2020 年至 2032 年全球 OTC 外用抗真菌藥物市場(依使用者分類)

  • 成人
  • 孩子們
  • 老年人

8. 2020 年至 2032 年全球 OTC 外用抗真菌藥物市場(依分銷管道)

  • 網路藥局
  • 零售藥局
  • 超級市場/大賣場
  • 專賣店

9. 2020 年至 2032 年全球非處方抗真菌藥物市場(按地區)

  • 北美洲
      • 美國
      • 加拿大
  • 拉丁美洲
      • 巴西
      • 阿根廷
      • 墨西哥
      • 其他拉丁美洲
  • 歐洲
      • 德國
      • 英國
      • 西班牙
      • 法國
      • 義大利
      • 俄羅斯
      • 其他歐洲國家
  • 亞太地區
      • 中國
      • 印度
      • 日本
      • 澳洲
      • 韓國
      • ASEAN
      • 其他亞太地區
  • 中東
      • 海灣合作理事會國家
      • 以色列
      • 其他中東地區
  • 非洲
      • 南非
      • 北非
      • 中部非洲

第10章 競爭格局

  • Johnson & Johnson
  • Bayer AG
  • GlaxoSmithKline
  • Pfizer Inc.
  • Novartis AG
  • Merck & Co., Inc.
  • Abbott Laboratories
  • Sanofi SA
  • Astellas Pharma Inc.
  • Mylan NV
  • Amgen Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Valeant Pharmaceuticals International
  • Reddy's Laboratories
  • Sun Pharmaceutical Industries Ltd.

第 11 章分析師建議

  • 機會
  • 分析師觀點
  • Coherent Opportunity Map

第12章參考文獻與調查方法

  • 參考
  • 調查方法
  • 關於出版商
簡介目錄
Product Code: CMI7970

Global OTC Topical Antifungals Market is estimated to be valued at USD 3.28 Bn in 2025 and is expected to reach USD 4.90 Bn by 2032, growing at a compound annual growth rate (CAGR) of 5.9% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 3.28 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.90% 2032 Value Projection: USD 4.90 Bn

The global OTC topical antifungals market has witnessed significant growth in recent years, driven by the increasing prevalence of fungal infections and the rising demand for over-the-counter remedies. Topical antifungals are medications applied directly to the skin, nails, or hair to treat various fungal infections, such as athlete's foot, ringworm, and candidiasis. The market encompasses a wide range of products, including creams, ointments, sprays, and powders, which are readily available without a prescription. The convenience and accessibility of these products have contributed to their popularity among consumers seeking quick and effective relief from fungal infections. As awareness about personal hygiene and self-care continues to grow, the global OTC topical antifungals market is expected to expand further, offering lucrative opportunities for manufacturers and retailers alike.

Market Dynamics

The global OTC topical antifungals market is influenced by several key factors that drive its growth, pose challenges, and present opportunities. One of the primary drivers is the increasing prevalence of fungal infections worldwide, particularly in developing countries with tropical climates and poor hygiene conditions. The rising incidence of diabetes, which makes individuals more susceptible to fungal infections, also contributes to the market's growth. Additionally, the growing awareness about personal hygiene and the importance of prompt treatment for fungal infections has led to a higher demand for OTC topical antifungals. However, the market faces certain restraints, such as the availability of alternative treatment options, including prescription medications and home remedies, which may limit its growth potential. Moreover, the side effects associated with some topical antifungals, such as skin irritation and allergic reactions, may deter some consumers from using these products. Despite these challenges, the market presents significant opportunities for manufacturers to develop innovative and targeted formulations that address specific consumer needs and preferences. The increasing demand for natural and organic antifungal products, as well as the potential for expansion into emerging markets, offers promising avenues for growth in the global OTC topical antifungals market.

Key Features of the Study

  • This report provides in-depth analysis of the global OTC topical antifungals market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global OTC topical antifungals market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include Johnson & Johnson, Bayer AG, GlaxoSmithKline, Pfizer Inc., Novartis AG, Merck & Co., Inc., Abbott Laboratories, Sanofi S.A., Astellas Pharma Inc., Mylan N.V., Amgen Inc., Teva Pharmaceutical Industries Ltd., Valeant Pharmaceuticals International, Dr. Reddy's Laboratories, and Sun Pharmaceutical Industries Ltd.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global OTC topical antifungals market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global OTC topical antifungals market

Market Segmentation

  • Product Type Insights (Revenue, USD Bn, 2020 - 2032)
    • Creams
    • Ointments
    • Sprays
    • Powders
    • Gels
    • Lotions
  • Active Ingredient Insights (Revenue, USD Bn, 2020 - 2032)
    • Clotrimazole
    • Miconazole
    • Terbinafine
    • Ketoconazole
    • Tolnaftate
    • Others
  • Application Insights (Revenue, USD Bn, 2020 - 2032)
    • Dermatophyte Infections
    • Yeast Infections
    • Nail Infections
    • Ringworm
    • Athlete's Foot
  • User Insights (Revenue, USD Bn, 2020 - 2032)
    • Adults
    • Pediatrics
    • Geriatrics
  • Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
    • Online Pharmacies
    • Retail Pharmacies
    • Supermarkets/Hypermarkets
    • Specialty Stores
  • Regional Insights (Revenue, USD Bn, 2020 - 2032)
    • North America
    • U.S.
    • Canada
    • Latin America
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
    • Europe
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
    • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
    • GCC Countries
    • Israel
    • Rest of Middle East
    • Africa
    • South Africa
    • North Africa
    • Central Africa
  • Key Players Insights
    • Johnson & Johnson
    • Bayer AG
    • GlaxoSmithKline
    • Pfizer Inc.
    • Novartis AG
    • Merck & Co., Inc.
    • Abbott Laboratories
    • Sanofi S.A.
    • Astellas Pharma Inc.
    • Mylan N.V.
    • Amgen Inc.
    • Teva Pharmaceutical Industries Ltd.
    • Valeant Pharmaceuticals International
    • Reddy's Laboratories
    • Sun Pharmaceutical Industries Ltd.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Global OTC Topical Antifungals Market, By Product Type
    • Global OTC Topical Antifungals Market, By Active Ingredient
    • Global OTC Topical Antifungals Market, By Application
    • Global OTC Topical Antifungals Market, By User
    • Global OTC Topical Antifungals Market, By Distribution Channel
    • Global OTC Topical Antifungals Market, By Region

3. Market Dynamics, Regulations,and Trends Analysis

  • Market Dynamics
  • Driver
  • Restraint
  • Opportunity
  • Impact Analysis
  • Key Developments
  • Regulatory Scenario
  • Product Launches/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario
  • Industry Trends

4. Global OTC Topical Antifungals Market, By Product Type, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Creams
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ointments
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Sprays
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Powders
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Gels
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Lotions
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global OTC Topical Antifungals Market, By Active Ingredient, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Clotrimazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Miconazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Terbinafine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ketoconazole
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tolnaftate
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global OTC Topical Antifungals Market, By Application, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Dermatophyte Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Yeast Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Nail Infections
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ringworm
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Athlete's Foot
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global OTC Topical Antifungals Market, By User, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Pediatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Geriatrics
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global OTC Topical Antifungals Market, By Distribution Channel, 2020-2032, (USD Bn)

  • Introduction
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Online Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Retail Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Supermarkets/Hypermarkets
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Specialty Stores
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global OTC Topical Antifungals Market, By Region, 2020 - 2032, Value (USD Bn)

  • Introduction
    • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
    • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Brazil
      • Argentina
      • Mexico
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • Germany
      • U.K.
      • Spain
      • France
      • Italy
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • China
      • India
      • Japan
      • Australia
      • South Korea
      • ASEAN
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Active Ingredient, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By User, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
    • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
      • South Africa
      • North Africa
      • Central Africa

10. Competitive Landscape

  • Johnson & Johnson
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • GlaxoSmithKline
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Pfizer Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Novartis AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co., Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Abbott Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sanofi S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Astellas Pharma Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Mylan N.V.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Amgen Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Teva Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Valeant Pharmaceuticals International
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Reddy's Laboratories
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Sun Pharmaceutical Industries Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

11. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

12. References and Research Methodology

  • References
  • Research Methodology
  • About us